Latest Government Approvals News

Cue Energy Resources posted a solid quarter with a 16% production rise and $13.6 million cash receipts, backed by new drilling and a refreshed board after Horizon Oil's takeover.

Horizon Oil achieved record production and sales in FY26, driven by its Thailand assets, and completed the off-market takeover of Cue Energy, expanding its footprint across five countries.

Lion Energy has locked in funding and government approval for its Bula Karang-1 well in Indonesia, targeting a September spud, while winding down its hydrogen project to focus on core upstream oil and gas activities.

Tasman Resources (ASX:TAS) is gearing up for a significant ramp-up in drilling activity across its Lake Torrens and Parkinson Dam projects, with Fortescue (ASX:FMG) set to drill two maiden holes at the Titan West IOCG target starting late August 2026. Meanwhile, Tasman plans up to twenty new drill holes at Parkinson Dam targeting high-priority epithermal and hydrothermal prospects.

Tasman Resources is gearing up for dual drilling campaigns at Lake Torrens and Parkinson Dam, supported by a recent $4 million placement and strategic asset sales.

NH3 Clean Energy has completed critical environmental surveys for its WAH2 Project, confirming no threatened species or ecological communities in the development area. This milestone supports upcoming State and Commonwealth approval submissions, advancing the project towards its final investment decision.

Terrain Minerals (ASX: TMX) delivered a strong June quarter update, confirming high-grade gold and silver mineralisation at its Smokebush flagship, progressing a maiden resource estimate at Lightning, and reporting broad rare earth and lithium anomalies at Lort River and Carlindie projects.

Coast Entertainment has unlocked a major milestone with Queensland Government approval for its Coomera landholding development, while reporting robust FY26 trading with double-digit growth in ticket sales and revenue.

Connected Minerals is set to acquire Frontier Group, gaining control of an 80% stake in the high-grade Bailundo carbonatite project in Angola, backed by a $4.5 million capital raise and planned drilling.

Island Pharmaceuticals is progressing its broad-spectrum antiviral Galidesivir amid a severe Ebola outbreak, securing government approvals in Uganda and outlining a dual clinical and regulatory development pathway targeting multiple deadly filoviruses.

West African Resources delivered 125,179 ounces of gold in Q2 2026, maintaining momentum toward its full-year guidance amid ongoing permitting hurdles and a major equity transaction at Kiaka.

Racura Oncology has secured Bellberry HREC approval for its HARNESS-1 lung cancer trial, enabling expansion to additional Australian sites including Chris O’Brien Lifehouse and Austin Health, setting the stage for accelerated patient enrolment.